Skip to main navigation Skip to search Skip to main content

Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting

  • S. Ribero*
  • , A. Ramondetta
  • , G. Fabbrocini
  • , V. Bettoli
  • , C. Potenza
  • , Andrea Chiricozzi
  • , M. Licciardello
  • , A. V. Marzano
  • , L. Bianchi
  • , G. Rozzo
  • , L. Fania
  • , C. Marasca
  • , G. Odorici
  • , A. Mambrin
  • , C. Moltrasio
  • , Caro R. D. Caposiena
  • , N. Skroza
  • , P. Quaglino
  • , N. Siliquini
  • , P. Dapavo
  • *Corresponding author
  • University of Turin
  • University of Naples Federico II
  • University of Ferrara
  • University of Rome La Sapienza
  • IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
  • University of Milan
  • University of Rome Tor Vergata
  • IRCCS Istituto Dermopatico dell'Immacolata - Roma
  • University of Trieste

Research output: Contribution to journalArticle

Abstract

N/A
Original languageEnglish
Pages (from-to)e441-e442
JournalJournal of the European Academy of Dermatology and Venereology
Issue number35
DOIs
Publication statusPublished - 2021

All Science Journal Classification (ASJC) codes

  • Dermatology
  • Infectious Diseases

Keywords

  • hidradenitis suppurativa

Fingerprint

Dive into the research topics of 'Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting'. Together they form a unique fingerprint.

Cite this